Ligand validation:7VEL

O4B: 1,4,7,10,13,16-HEXAOXACYCLOOCTADECANE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7VEL_O4B_A_602	73%	72%	0.109	0.936	0.55	0.53	-	-	0	0	100%	1
7VEK_O4B_A_501	63%	75%	0.172	0.967	0.57	0.42	-	-	0	0	100%	1
7VEJ_O4B_A_602	42%	71%	0.202	0.924	0.6	0.52	-	-	1	0	100%	1
6LZY_O4B_B_501	41%	94%	0.201	0.918	0.25	0.21	-	-	2	0	100%	1
7JY1_O4B_B_203	95%	96%	0.067	0.972	0.16	0.2	-	-	0	0	100%	1
3WUR_O4B_B_202	94%	44%	0.067	0.964	1.23	0.96	1	1	0	0	100%	1
5ZW2_O4B_A_503	92%	64%	0.08	0.969	0.59	0.78	-	-	0	0	100%	1
7JY3_O4B_B_203	91%	97%	0.073	0.959	0.16	0.17	-	-	0	0	100%	1
6AF6_O4B_A_503	90%	72%	0.084	0.965	0.63	0.47	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.